scorecardresearch
Tuesday, February 25, 2025
Support Our Journalism
HomeIndiaIndia's Cipla beats Q3 profit view on strong demand in North America

India’s Cipla beats Q3 profit view on strong demand in North America

Follow Us :
Text Size:

HYDERABAD/BENGALURU (Reuters) – Cipla, one of India’s largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by strong demand, especially in the key North American market.

The company’s consolidated net profit increased nearly 49% to 15.71 billion rupees ($181.6 million) in the October-December quarter, beating analysts’ estimate of 12.12 billion rupees, as per LSEG data.

($1 = 86.5325 Indian rupees)

(Reporting by Rishika Sadam in Hyderabad and Kashish Tandon in Bengaluru; Editing by Eileen Soreng)

Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular